Targeting a Regulator of Inflammation to Treat Alzheimer’s Disease

David Bearss, president and CEO of Halia Therapeutics, discusses the NLRP3 inflammasome, the role it plays in Alzheimer’s disease and other neurologic conditions, and the case for its therapeutic approach.

Om Podcasten

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.